Durect (DRRX) News and press releases

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023

14 Mar 23

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

JonesTrading Initiates Coverage On Durect with Buy Rating, Announces Price Target of $37

14 Mar 23

News, Price Target, Initiation, Analyst Ratings

JonesTrading analyst Sean Kim initiates coverage on Durect (NASDAQ:DRRX) with a Buy rating and announces Price Target of $37.

Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday

8 Mar 23

News, Penny Stocks, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas

HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75 on Monday.

HC Wainwright & Co. Maintains Buy on Durect, Lowers Price Target to $32

8 Mar 23

News, Price Target, Analyst Ratings

HC Wainwright & Co. analyst Ed Arce maintains Durect (NASDAQ:DRRX) with a Buy and lowers the price target from $35 to $32.

Durect Q4 EPS $(0.46) Beats $(0.55) Estimate, Sales $3.30M Miss $3.48M Estimate

7 Mar 23

Earnings, News

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.55) by 16.36 percent. This is a 53.33 percent decrease over losses of $(0.30) per share from the same

Earnings Scheduled For March 7, 2023

7 Mar 23

Earnings

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for its fourth quarter. • Xtant Medical Holdings (AMEX:XTNT) is expected to report earnings for its fourth quarter.

Durect's Earnings Outlook

6 Mar 23

Earnings

12 Health Care Stocks Moving In Monday's Pre-Market Session

6 Feb 23

Movers

5 Most Expensive Health Care Stocks You Should Worry About

12 Jan 23

News, Penny Stocks, Short Ideas, Pre-Market Outlook, Markets, Trading Ideas

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Stocks That Hit 52-Week Lows On Tuesday

3 Jan 23

Options

On Tuesday, 31 stocks hit new 52-week lows.

DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board

21 Mar 23

Press Releases

CUPERTINO, Calif., March 21, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) announced today that Gail Maderis has assumed the role of Chair of the Board of DURECT effective March 17, 2023. Ms. Maderis succeeds

DURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare Conference

9 Mar 23

Press Releases

CUPERTINO, Calif., March 9, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that Dr. James Brown, President and CEO and additional members of the management team will participate in a fireside chat

DURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Update

7 Mar 23

Earnings, Press Releases

- Webcast of Earnings Call Today, March 7th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in 2023 CUPERTINO, Calif., March 7, 2023 /PRNewswire / -- DURECT Corporation (NASDAQ:DRRX) today announced financial

DURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7

28 Feb 23

Press Releases

CUPERTINO, Calif., Feb. 28, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that it will report its fourth quarter and full year 2022 financial results and host a conference call after the market

DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants

3 Feb 23

Offerings, Press Releases

CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ